These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 18974024)

  • 1. Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression.
    Hoffman LR; Kulasekara HD; Emerson J; Houston LS; Burns JL; Ramsey BW; Miller SI
    J Cyst Fibros; 2009 Jan; 8(1):66-70. PubMed ID: 18974024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients.
    D'Argenio DA; Wu M; Hoffman LR; Kulasekara HD; Déziel E; Smith EE; Nguyen H; Ernst RK; Larson Freeman TJ; Spencer DH; Brittnacher M; Hayden HS; Selgrade S; Klausen M; Goodlett DR; Burns JL; Ramsey BW; Miller SI
    Mol Microbiol; 2007 Apr; 64(2):512-33. PubMed ID: 17493132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucoidy, quorum sensing, mismatch repair and antibiotic resistance in Pseudomonas aeruginosa from cystic fibrosis chronic airways infections.
    Feliziani S; Luján AM; Moyano AJ; Sola C; Bocco JL; Montanaro P; Canigia LF; Argaraña CE; Smania AM
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants.
    Ciofu O; Mandsberg LF; Bjarnsholt T; Wassermann T; Høiby N
    Microbiology (Reading); 2010 Apr; 156(Pt 4):1108-1119. PubMed ID: 20019078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LasR Variant Cystic Fibrosis Isolates Reveal an Adaptable Quorum-Sensing Hierarchy in Pseudomonas aeruginosa.
    Feltner JB; Wolter DJ; Pope CE; Groleau MC; Smalley NE; Greenberg EP; Mayer-Hamblett N; Burns J; Déziel E; Hoffman LR; Dandekar AA
    mBio; 2016 Oct; 7(5):. PubMed ID: 27703072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutrient availability as a mechanism for selection of antibiotic tolerant Pseudomonas aeruginosa within the CF airway.
    Hoffman LR; Richardson AR; Houston LS; Kulasekara HD; Martens-Habbena W; Klausen M; Burns JL; Stahl DA; Hassett DJ; Fang FC; Miller SI
    PLoS Pathog; 2010 Jan; 6(1):e1000712. PubMed ID: 20072604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quorum Sensing Down-Regulation Counteracts the Negative Impact of
    Maillé É; Ruffin M; Adam D; Messaoud H; Lafayette SL; McKay G; Nguyen D; Brochiero E
    Front Cell Infect Microbiol; 2017; 7():470. PubMed ID: 29177135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug-resistant
    Ding F; Han L; Xue Y; Yang IT; Fan X; Tang R; Zhang C; Zhu M; Tian X; Shao P; Zhang M
    Front Cell Infect Microbiol; 2022; 12():934439. PubMed ID: 35967851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Codon-usage frequency mediated SNPs selection in lasR gene of cystic fibrosis Pseudomonas aeruginosa isolates.
    Qiu H; Li Y; Dai W
    Microbiol Res; 2019; 223-225():137-143. PubMed ID: 31178047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evolution of Pseudomonas aeruginosa AA2 biofilms in the presence of cystic fibrosis lung microbiome members.
    Vandeplassche E; Sass A; Lemarcq A; Dandekar AA; Coenye T; Crabbé A
    Sci Rep; 2019 Sep; 9(1):12859. PubMed ID: 31492943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SERS detection of the biomarker hydrogen cyanide from Pseudomonas aeruginosa cultures isolated from cystic fibrosis patients.
    Lauridsen RK; Sommer LM; Johansen HK; Rindzevicius T; Molin S; Jelsbak L; Engelsen SB; Boisen A
    Sci Rep; 2017 Mar; 7():45264. PubMed ID: 28349938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas aeruginosa lasR transcription correlates with the transcription of lasA, lasB, and toxA in chronic lung infections associated with cystic fibrosis.
    Storey DG; Ujack EE; Rabin HR; Mitchell I
    Infect Immun; 1998 Jun; 66(6):2521-8. PubMed ID: 9596711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of Pseudomonas aeruginosa virulence in infected patients revealed in a Dictyostelium discoideum host model.
    Lelong E; Marchetti A; Simon M; Burns JL; van Delden C; Köhler T; Cosson P
    Clin Microbiol Infect; 2011 Sep; 17(9):1415-20. PubMed ID: 21091830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection.
    Coleman FT; Mueschenborn S; Meluleni G; Ray C; Carey VJ; Vargas SO; Cannon CL; Ausubel FM; Pier GB
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1949-54. PubMed ID: 12578988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung.
    Hogardt M; Heesemann J
    Curr Top Microbiol Immunol; 2013; 358():91-118. PubMed ID: 22311171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucoid Pseudomonas aeruginosa isolates maintain the biofilm formation capacity and the gene expression profiles during the chronic lung infection of CF patients.
    Lee B; Schjerling CK; Kirkby N; Hoffmann N; Borup R; Molin S; Høiby N; Ciofu O
    APMIS; 2011 Apr; 119(4-5):263-74. PubMed ID: 21492226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptation of Pseudomonas aeruginosa to the chronic phenotype by mutations in the algTmucABD operon in isolates from Brazilian cystic fibrosis patients.
    Candido Caçador N; Paulino da Costa Capizzani C; Gomes Monteiro Marin Torres LA; Galetti R; Ciofu O; da Costa Darini AL; Høiby N
    PLoS One; 2018; 13(11):e0208013. PubMed ID: 30496246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is infection with hypermutable Pseudomonas aeruginosa clinically significant?
    Auerbach A; Kerem E; Assous MV; Picard E; Bar-Meir M
    J Cyst Fibros; 2015 May; 14(3):347-52. PubMed ID: 25308183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis.
    Hoboth C; Hoffmann R; Eichner A; Henke C; Schmoldt S; Imhof A; Heesemann J; Hogardt M
    J Infect Dis; 2009 Jul; 200(1):118-30. PubMed ID: 19459782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.